Search Results - Ulrich Jaeger

  • Showing 1 - 12 results of 12
Refine Results
  1. 1

    Response to comment by P. Vassilakopoulos and colleagues by Ulrich Jaeger, Michael Praxmarer, Richard Greil

    Published in Haematologica (2015-11-01)
    Get full text
    Article


  2. 2

    A decade of collaboration in medicines regulation: healthcare professionals engaging with the European Medicines Agency by Ivana Silva, Giulia Gabrielli, Juan Garcia Burgos, Isabelle Moulon, Gonzalo Calvo Rojas, Ulrich Jaeger, Ulrich Jaeger, Rosa Giuliani

    Published in Frontiers in Medicine (2024-06-01)
    Get full text
    Article


  3. 3

    Towards a joint definition of European hematology by Gert Ossenkoppele, Gareth Evans-Jones, Ulrich Jaeger, Eva Hellström-Lindberg

    Published in Haematologica (2012-05-01)
    Get full text
    Article


  4. 4

    Mechanical power density, spontaneous breathing indexes, and prolonged weaning failure: a prospective cohort study by Alessandro Ghiani, Swenja Walcher, Azal Lutfi, Joanna Paderewska, Simon Ulrich Jaeger, Nikolaus Kneidinger, Stephanie Susanne Stecher, Franziska Christina Trudzinski, Claus Neurohr

    Published in Scientific Reports (2024-07-01)
    Get full text
    Article


  5. 5

    Phase II single-arm study of a combination of obinutuzumab and venetoclax in early relapsed or refractory diffuse large B-cell lymphoma—final results of the AGMT NHL15B study by Ulrich Jaeger, Ulrich Jaeger, Ingrid Simonitsch-Klupp, Patrick Klammer, Alexander Egle, Sonja Heibl, Peter Neumeister, Ella Willenbacher, Florian Erlsbacher, Julian Larcher-Senn, Philipp B. Staber, Edit Porpaczy, Cathrin Skrabs, Marius E. Mayerhoefer, Marius E. Mayerhoefer, Marcus Hacker, Thomas Melchardt, Michael A. Fridrik, Richard Greil, Richard Greil

    Published in Frontiers in Hematology (2024-03-01)
    Get full text
    Article


  6. 6

    Health Economic Aspects of Chimeric Antigen Receptor T-cell Therapies for Hematological Cancers: Present and Future by Renaud Heine, Frederick W. Thielen, Marc Koopmanschap, Marie José Kersten, Hermann Einsele, Ulrich Jaeger, Pieter Sonneveld, Jorge Sierra, Carin Smand, Carin A. Uyl-de Groot

    Published in HemaSphere (2021-02-01)
    Get full text
    Article


  7. 7

    Long‐term immune changes in patients with relapsed/refractory chronic lymphocytic leukemia following treatment with venetoclax plus rituximab by Arnon P. Kater, Barbara F. Eichhorst, Carolyn J. Owen, Ulrich Jaeger, Brenda Chyla, Marcus Lefebure, Rosemary Millen, Yanwen Jiang, Maria Thadani‐Mulero, Michelle Boyer, John F. Seymour

    Published in HemaSphere (2024-08-01)
    Get full text
    Article


  8. 8

    S201: FINAL 7-YEAR FOLLOW UP AND RETREATMENT SUBSTUDY ANALYSIS OF MURANO: VENETOCLAX-RITUXIMAB (VENR)-TREATED PATIENTS WITH RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA (R/R CL... by Arnon Kater, Rosemary Harrup, Thomas J Kipps, Barbara Eichhorst, Carolyn J Owen, Sarit Assouline, Nicole Lamanna, Tadeusz Robak, Javier de la Serna, Ulrich Jaeger, Guillaume Cartron, Marco Montillo, Clemens Mellink, Brenda Chyla, Maria Thadani-Mulero, Marcus Lefebure, Yanwen Jiang, Rosemary Millen, Michelle Boyer, John F Seymour

    Published in HemaSphere (2023-08-01)
    Get full text
    Article


  9. 9

    Rituximab maintenance for patients with aggressive B-cell lymphoma in first remission: results of the randomized NHL13 trial by Ulrich Jaeger, Marek Trneny, Helen Melzer, Michael Praxmarer, Weerasak Nawarawong, Dina Ben Yehuda, David Goldstein, Bilijana Mihaljevic, Osman Ilhan, Veronika Ballova, Michael Hedenus, Liang-Tsai Hsiao, Wing-Yan Au, Sonja Burgstaller, Gerhard Weidinger, Felix Keil, Christian Dittrich, Cathrin Skrabs, Anton Klingler, Andreas Chott, Michael A. Fridrik, Richard Greil

    Published in Haematologica (2015-07-01)
    Get full text
    Article


  10. 10

    PB2707: ESMO-MAGNITUDE OF CLINICAL BENEFIT SCALE FOR HAEMATOLOGICAL MALIGNANCIES (ESMO-MCBS:H) VERSION 1.0 by Barbara Kiesewetter, Urania Dafni, Elisabeth G E de Vries, Jorge Barriuso, Giuseppe Curigliano, Veronica González-Calle, Martina Galotti, Bishal Gyawali, Brian Huntly, Ulrich Jaeger, Nicola Jane Latino, Luca Malcovati, Sjoukje Oosting, Gert Ossenkoppele, Martine Piccart, Markus Raderer, Lydia Scarfò, Dario Trapani, Christoph C Zielinski, Ruth Wester, Panagiota Zygoura, Elizabeth Macintyre, Nathan I Cherny

    Published in HemaSphere (2023-08-01)
    Get full text
    Article


  11. 11

    Characterization of atrial fibrillation adverse events reported in ibrutinib randomized controlled registration trials by Jennifer R. Brown, Javid Moslehi, Susan O’Brien, Paolo Ghia, Peter Hillmen, Florence Cymbalista, Tait D. Shanafelt, Graeme Fraser, Simon Rule, Thomas J. Kipps, Steven Coutre, Marie-Sarah Dilhuydy, Paula Cramer, Alessandra Tedeschi, Ulrich Jaeger, Martin Dreyling, John C. Byrd, Angela Howes, Michael Todd, Jessica Vermeulen, Danelle F. James, Fong Clow, Lori Styles, Rudy Valentino, Mark Wildgust, Michelle Mahler, Jan A. Burger

    Published in Haematologica (2017-10-01)
    Get full text
    Article


  12. 12

    Ofatumumab in poor-prognosis chronic lymphocytic leukemia: a Phase IV, non-interventional, observational study from the European Research Initiative on Chronic Lymphocytic Leukemia by Carol Moreno, Marco Montillo, Panayiotis Panayiotidis, Maria Dimou, Adrian Bloor, Jehan Dupuis, Anna Schuh, Stefan Norin, Christian Geisler, Peter Hillmen, Michael Doubek, Marek Trněný, Petra Obrtlikova, Luca Laurenti, Stephan Stilgenbauer, Lukas Smolej, Paolo Ghia, Florence Cymbalista, Ulrich Jaeger, Kostas Stamatopoulos, Niki Stavroyianni, Patrick Carrington, Hamadi Zouabi, Veronique Leblond, Juan C. Gomez-Garcia, Martin Rubio, Roberto Marasca, Gerardo Musuraca, Luigi Rigacci, Lucia Farina, Rossella Paolini, Sarka Pospisilova, Eva Kimby, Colm Bradley, Emili Montserrat

    Published in Haematologica (2015-04-01)
    Get full text
    Article


Search Tools: